Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
Bays HE, Banach M, Catapano AL, Duell PB, Gotto AM Jr, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Bloedon LT, Sasiela WJ, Ye Z, Ballantyne CM. Bays HE, et al. Among authors: mancini gbj. J Clin Lipidol. 2020 Sep-Oct;14(5):649-659.e6. doi: 10.1016/j.jacl.2020.08.009. Epub 2020 Sep 2. J Clin Lipidol. 2020. PMID: 32980290 Free article.
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.
Leiter LA, Banach M, Catapano AL, Duell PB, Gotto AM Jr, Laufs U, Mancini GBJ, Ray KK, Hanselman JC, Ye Z, Bays HE. Leiter LA, et al. Among authors: mancini gbj. Diabetes Obes Metab. 2022 May;24(5):868-880. doi: 10.1111/dom.14645. Epub 2022 Feb 3. Diabetes Obes Metab. 2022. PMID: 34981622 Free PMC article. Clinical Trial.
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
Laufs U, Ballantyne CM, Banach M, Bays H, Catapano AL, Duell PB, Goldberg AC, Gotto AM, Leiter LA, Ray KK, Bloedon LT, MacDougall D, Zhang Y, Mancini GBJ. Laufs U, et al. Among authors: mancini gbj. J Clin Lipidol. 2022 May-Jun;16(3):286-297. doi: 10.1016/j.jacl.2022.03.001. Epub 2022 Mar 13. J Clin Lipidol. 2022. PMID: 35346603 Free article. Clinical Trial.
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
Nissen SE, Dent-Acosta RE, Rosenson RS, Stroes E, Sattar N, Preiss D, Mancini GB, Ballantyne CM, Catapano A, Gouni-Berthold I, Stein EA, Xue A, Wasserman SM, Scott R, Thompson PD; GAUSS-3 Investigators. Nissen SE, et al. Clin Cardiol. 2016 Mar;39(3):137-44. doi: 10.1002/clc.22518. Epub 2016 Mar 4. Clin Cardiol. 2016. PMID: 26946077 Free PMC article. Clinical Trial.
Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
Rosenson RS, Baker S, Banach M, Borow KM, Braun LT, Bruckert E, Brunham LR, Catapano AL, Elam MB, Mancini GBJ, Moriarty PM, Morris PB, Muntner P, Ray KK, Stroes ES, Taylor BA, Taylor VH, Watts GF, Thompson PD. Rosenson RS, et al. Among authors: mancini gbj. J Am Coll Cardiol. 2017 Sep 5;70(10):1290-1301. doi: 10.1016/j.jacc.2017.07.752. J Am Coll Cardiol. 2017. PMID: 28859793 Free article. Review.
GOAL Canada: Physician Education and Support Can Improve Patient Management.
Langer A, Tan M, Goodman SG, Grégoire J, Lin PJ, Mancini GBJ, Stone JA, Wills C, Spindler C, Leiter LA. Langer A, et al. Among authors: mancini gbj. CJC Open. 2019 Dec 28;2(2):49-54. doi: 10.1016/j.cjco.2019.12.002. eCollection 2020 Mar. CJC Open. 2019. PMID: 32190825 Free PMC article.
262 results